BLLN
BillionToOne, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$98.12
−4.49%Price chart
Sep 17Sep 22Sep 25Sep 30Oct 5Oct 8Oct 13Oct 16
Key dataOct 16, 2026
Open$101.41
From 52W high−34.57%
Volume605354.00
Market cap$4.63B
P/E (TTM)142.2x
P/S (TTM)11.7x
Div yield—
Key dataOct 16, 2026
Open
$101.41
From 52W high
−34.57%
Volume
605354.00
Market cap
$4.63B
ValuationView details →
P/E (Fwd)
115.1x
EV/EBITDA
84.1x
P/E (TTM)
142.2x
RSI (14)
44.9
MomentumView details →
1D Return
−4.49%
YTD Return
+19.72%
Similar companies
Latest newsMore news →
BillionToOne, Inc. announced that it plans to release financial results for the third quarter ended September 30, 2026, after market close on November 4, 2026, and hold a conference call that day.2d agoBillionToOne launched Northstar Origin, a new liquid biopsy add-on test for tissue-of-origin prediction, and expanded its Northstar Select panel from 84 to 102 genes.45d ago